Behandlingsvarigheden af den intravenøse behandling var 13, 5 dage (spredning 1- 38 dage) hos disse patienter.
A total of 204 patients received the recommended daily dose of 100 mg; the mean duration of intravenous treatment in these patients was 13.5 days (range, 1 to 38 days).